International study validates efficacy of a drug in adults with neurofibromatosis type 1
An international study has shown that a drug called selumetinib can reduce the pain and size of tumors caused in adults by neurofibromatosis type 1 (NF1), a rare genetic disease for which there is currently no effective pharmacological ...
Jun 25, 2025
0
12
